BMY vs XAIR · P/E 17, rev $24.46B vs rev $7.7M
Bristol-Myers Squibb Company (BMY) versus Beyond Air Inc (XAIR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Beyond Air Inc (XAIR) is a medical devices company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported XAIR revenue for 2026-03-31 was $7.7M. Net income was -$33.2M. Revenue was up 107.3% from 2025-03-31 to 2026-03-31. XAIR currently screens at market cap $16.0M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. XAIR currently screens at market cap $16.0M.
Not investment advice. Open the BMY and XAIR stock pages for the full models.
Not investment advice.